Insider trading

Period: 120 months Stock: PMVP Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

13 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

13 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

13 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

13 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
13 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
13 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

13 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
1 Jul 2025
Jalota Deepika Chief Development Officer
Sold at will
$35.20K 33,065 at 1.06
26.9%
Not planned
1 Jul 2025
Ticktin Robert General Counsel & COO
Sold at will
$24.65K 23,151 at 1.06
19.0%
Not planned
11 Sep 2024
Jalota Deepika Chief Development Officer
Sold at will
$10.85K 7,218 at 1.50
5.8%
Not planned
15 Sep 2023
Alland Leila Chief Medical Officer
Sold at will
$41.65K 6,291 at 6.62
12.1%
Not planned
15 Sep 2023
Jalota Deepika Chief Development Officer
Sold at will
$27.17K 4,104 at 6.62
12.1%
Not planned
9 Sep 2021
Alland Leila Chief Medical Officer
Sold, plan not stated
$3.03K 100 at 30.25
100%
Sold half or more
7 Sep 2021
Alland Leila Chief Medical Officer
Sold, plan not stated
$117.98K 3,900 at 30.25
100%
Sold half or more
17 Aug 2021
Jalota Deepika SVP, Regulatory Affairs and QA
Sold, plan not stated
$97.81K 2,896 at 33.78
100%
Sold half or more
9 Aug 2021
Alland Leila Chief Medical Officer
Sold, plan not stated 3×
$152.20K 4,471 at 34.04
100%
Sold half or more
7 Jul 2021
Alland Leila Chief Medical Officer
Sold, plan not stated 2×
$129.21K 4,000 at 32.30
100%
Sold half or more
7 Jun 2021
Alland Leila Chief Medical Officer
Sold, plan not stated 2×
$134.39K 4,000 at 33.60
100%
Sold half or more
7 May 2021
Alland Leila Chief Medical Officer
Sold, plan not stated 2×
$139.31K 4,000 at 34.83
100%
Sold half or more
7 Apr 2021
Alland Leila Chief Medical Officer
Sold, plan not stated 2×
$135.44K 4,000 at 33.86
100%
Sold half or more
Showing 1–13 of 13.